abstract |
The invention relates to peptides according to general formula (I) GX1CSX2SX3PPX4CX5PD where X1 isY,M,W,I,V,A,andX2 is R,K,and X3 isY,F,I,M, L, E, D, H, and X4 is V, I, H, and X5 is I, V, Y, F, W; and to their pharmaceutically acceptable salts, esters and prodrugs. Furthermore the invention relates to pharmaceutical preparations and kits containing them, and to screening and isolation procedures using them, and to their use in the production of pharmaceutical preparations. |